About: Contraindicated use of cisapride: impact of food and drug administration regulatory action

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Contraindicated use of cisapride: impact of food and drug administration regulatory action Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 December 2000

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в грудні 2000 (uk) مقالة علمية تنشرت ف 1 دجنبر 2000 (ary) im Dezember 2000 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu n'avientu de 2000 (ast) scientific article published on 01 December 2000 (en)
publication date	wds:Q73310907-363C896A-6838-48D8-B278-7EC4B75B0F0B
publication date	2000-12-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q73310907-B7371A72-85F2-4013-9A4F-B155718CAA81
language of work or name	English
author name string	wds:Q73310907-2AAA3399-DDCF-4C6A-84F8-49337898C375 wds:Q73310907-390C96A4-367E-4EFE-B0C1-F3E25AB41BFB wds:Q73310907-738109A4-4622-4C8D-B1C4-0B0F60359D28 wds:Q73310907-82A38D01-7216-4C42-A65C-ED188889838F wds:Q73310907-99005AA3-57E5-410F-AEF2-1FD5F3F87416 wds:Q73310907-9A44B0B4-196B-4D7C-A04B-B77E930D2DD2 wds:Q73310907-C4D48727-3FE3-483E-BBA8-EDA5E7C5534C wds:Q73310907-E812530C-492F-4B1D-9F75-4B7854216EA8 wds:Q73310907-EE469CA6-3431-49C6-9A92-38A77C8A3F45
author name string	R Platt M Goodman W A Ray D Shatin K A Chan S E Andrade D K Wysowski W Smalley S D Schech
rdfs:label	Contraindicated use of cisapride: impact of food and drug administration regulatory action (en) Contraindicated use of cisapride: impact of food and drug administration regulatory action (nl)
skos:prefLabel	Contraindicated use of cisapride: impact of food and drug administration regulatory action (en) Contraindicated use of cisapride: impact of food and drug administration regulatory action (nl)
name	Contraindicated use of cisapride: impact of food and drug administration regulatory action (en) Contraindicated use of cisapride: impact of food and drug administration regulatory action (nl)
author	wds:Q73310907-891B8E7C-E9AB-4A5E-8BD9-EA75DE98052F
author	Jerry H Gurwitz
title	wds:Q73310907-789A052F-E12A-4088-953C-B6D7A06DE878
title	Contraindicated use of cisapride: impact of food and drug administration regulatory action (en)
page(s)	wds:Q73310907-FB923D03-5B48-4E8E-A0EB-E335D01AA2F0
page(s)	3036-3039
instance of	wds:Q73310907-9AE7ED6F-A1F5-4FB1-869D-A77871BDEC88
instance of	scholarly article
main subject	wds:Q73310907-F57387A7-42E6-4C6E-9D9A-E806239A8DD0 wds:Q73310907-FFDD45AB-38C3-4126-BF48-D8CD633EB28D
main subject	contraindication cisapride
PubMed ID	wds:Q73310907-088EC252-330C-4F2F-8954-498FF5399CAA
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/11122591
PubMed ID	11122591
published in	wds:Q73310907-B628F2A6-2E77-43B6-AEA1-B9B1CEF5C7EB
published in	The Journal of the American Medical Association
issue	wds:Q73310907-A7C9EC86-CC62-46DF-82AA-0CCB22A02E2C
volume	wds:Q73310907-5F95EB4D-04A3-43E9-84A9-F7C0B5376167
issue	23
volume	284
DOI	wds:Q73310907-0D110C94-84F6-4929-8B9F-BA1EECD7523E
DOI	http://dx.doi.org/10.1001/JAMA.284.23.3036
DOI	10.1001/JAMA.284.23.3036
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q73310907
is cites work of	Application of the bradford hill criteria to assess the causality of cisapride-induced arrhythmia: a model for assessing causal association in pharmacovigilance Prescribing pattern of anti-Parkinson drugs in Japan: a trend analysis from 2005 to 2010 Contraindicated medications dispensed with cisapride: temporal trends in relation to the sending of 'Dear Doctor' letters Impact of FDA drug risk communications on health care utilization and health behaviors: a systematic review The impact in Japan of regulatory action on prescribing of dopamine receptor agonists: analysis of a claims database between 2005 and 2008. A decade of safety-related regulatory action in the Netherlands: a retrospective analysis of direct healthcare professional communications from 1999 to 2009. Therapeutic strategies for the management of delayed gastric emptying after pancreatic resection Hepatotoxicity of the thiazolidinediones Drug screening using a library of human induced pluripotent stem cell-derived cardiomyocytes reveals disease-specific patterns of cardiotoxicity Safety of non-antiarrhythmic drugs that prolong the QT interval or induce torsade de pointes: an overview Telithromycin use and spontaneous reports of hepatotoxicity Multicenter epidemiologic and health services research on therapeutics in the HMO Research Network Center for Education and Research on Therapeutics Pharmacogenetic aspects of drug-induced torsade de pointes: potential tool for improving clinical drug development and prescribing Systematic review: cardiovascular safety profile of 5-HT(4) agonists developed for gastrointestinal disorders Stimulated reporting: the impact of US food and drug administration-issued alerts on the adverse event reporting system (FAERS) Bridging the efficacy–effectiveness gap: a regulator's perspective on addressing variability of drug response The significance of QT interval in drug development Antipsychotic-related QTc prolongation, torsade de pointes and sudden death Monitoring the safety of medicines used off-label Pharmacoepidemiology of QT-interval prolonging drug administration in critically ill patients Adverse drug event monitoring at the Food and Drug Administration Towards understanding the de-adoption of low-value clinical practices: a scoping review The impact of emerging safety and effectiveness evidence on the use of physician-administered drugs: the case of bevacizumab for breast cancer Pharmacogenetics in drug regulation: promise, potential and pitfalls Incidence and possible causes of prescribing potentially hazardous/contraindicated drug combinations in general practice QT prolongation with antimicrobial agents: understanding the significance Prokinetics in diabetic gastroparesis Effect of regulatory warnings on antipsychotic prescription rates among elderly patients with dementia: a population-based time-series analysis. Impact of FDA black box advisory on antipsychotic medication use The Erice declaration : the critical role of communication in drug safety. Effectiveness of safety warnings in atypical antipsychotic drugs: an interrupted time-series analysis in Spain Regulatory action and moderate decrease in methylphenidate use among ADHD diagnosed patients aged five and under in Korea Effects of funding policy changes and health warnings on the use of erythropoiesis-stimulating agents Concerns about health care warnings and their impact on prescribing behaviour Communication of medical product risk: how effective is effective enough? Improving communication of drug risks to prevent patient injury: proceedings of a workshop Pharmacy students' knowledge of black box warnings Implementing Black Box Warnings (BBWs) in Health Information Systems: An Organizing Taxonomy Identifying Opportunities and Challenges Diagnosis and treatment of chronic gastroparesis and chronic intestinal pseudo-obstruction. CIOMS and ICH initiatives in pharmacovigilance and risk management: overview and implications

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software